Our partner is a publicly-traded biotechnology company based in Massachusetts, focused on developing therapeutics for patients with devastating diseases and unmet medical needs.
Prestige Scientific has partnered with this organization on over 38 searches across functions. Expansion efforts supported multiple assets from Preclinical through Phase III and led to the submittal and approval of an IPO.
Searches Completed
Successful IPO
FDA-approved BLA Received